Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × Erlotinib Hydrochloride × Clear all

NCT01965275 2017-05-08

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions